News | Cath Lab | October 23, 2025

Heartflow Introduces PCI Planning Tool

New Heartflow PCI Navigator to equip interventional cardiologists with pre-procedural insights to enable PCI planning.

Heartflow Introduces PCI Planning Tool

Heartflow PCI Navigator (Photo: Heartflow Inc.)


Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One platform. PCI Navigator is an integrated, AI-driven percutaneous coronary interventions (PCI) planning tool that gives interventional cardiologists a patient-specific 3D model — detailing anatomy, plaque composition, and lesion-specific physiology — all aligned to optimize potential stent placement. For the first time, interventional cardiologists can plan PCIs with relevant information brought together in one intuitive view before their patients are in the cath lab.

Heartflow will showcase PCI Navigator with live demonstrations at the Transcatheter Cardiovascular Therapeutics (TCT) conference, in San Francisco. 

PCI Navigator delivers a streamlined view of essential information for cath lab decision-making by integrating all relevant measurements, including IVUS-like and FFR-like pullback visualizations, into one seamless experience, which typically requires significant time and effort to obtain in the cath lab.

“Interventional cardiologists make some of the most critical decisions in coronary care, often with limited information before a case begins. CT-guided PCI addresses that information gap, harnessing insights from the CCTA pathway into a pre-procedural plan to provide physicians the clarity they need for each case. PCI Navigator puts Heartflow at the forefront of that shift,” said Campbell Rogers, M.D., F.A.C.C., Chief Medical Officer of Heartflow. “CCTA with Heartflow analysis helps ensure that all patients warranting invasive management are directed to the cath lab, while also reducing invasive angiograms and improving efficiency. PCI Navigator enhances planning for these patients by integrating anatomy, plaque, and lesion-specific physiology for the interventionalist’s review and input before the procedure.”

PCI Navigator will deliver a streamlined view of essential information for cath lab decision-making including:

  • Procedural Complexity: Lesion-specific FFRCT values, stenosis, plaque location and composition, as well as percent myocardium fed by a vessel, to help understand lesion significance in context.
  • Stent Landing Zones: Cross-sectional and longitudinal reconstructions providing lumen diameter and length measures alongside plaque morphology and stenosis severity to help precisely plan and guide procedures.
  • Planning for Optimal Outcomes: Physiology changes along the lesion (ΔFFRCT) to ensure the stenting procedure addresses the maximal flow gradient for optimal outcomes.

By bringing together information that interventional cardiologists need to plan procedures into a web-based interface, PCI Navigator may help streamline procedures with increased efficiency and clinical confidence for both patients and staff.

Additional information is available at heartflow.com.


Related Content

News | TCT

Oct. 23, 2025 — At TCT 2025, the Cardiovascular Research Foundation (CRF) announced the 2025 SET-10 (Scientific ...

Home October 31, 2025
Home
News | TCT

Oct. 29, 2025 — FastWave Medical presented new first-in-human (FIH) and pre-clinical data for its Sola coronary laser ...

Home October 30, 2025
Home
News | TCT

Aug. 27, 2025 – The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical trials and science ...

Home August 28, 2025
Home
News | TCT

May 5, 2025 — The TCT Geoffrey O. Hartzler Master Operator Award will be presented to Kenneth Rosenfield, MD, MSc ...

Home May 05, 2025
Home
News | TCT

Oct. 11, 2024 – As the pace of change accelerates in healthcare, the most pressing questions in cardiovascular medicine ...

Home October 16, 2024
Home
News | TCT

November 9, 2023 — Medinbox, a global provider of video integrated collaboration systems for interventional rooms and ...

Home November 09, 2023
Home
News | TCT

October 30, 2023 — Shockwave Medical, Inc., which develops technologies for the treatment of cardiovascular disease, has ...

Home October 30, 2023
Home
News | TCT

October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued ...

Home October 26, 2023
Home
News | TCT

October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in ...

Home October 25, 2023
Home
News | TCT

October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical ...

Home October 25, 2023
Home
Subscribe Now